CDTX
Price
$26.54
Change
+$0.29 (+1.10%)
Updated
May 22, 12:26 PM (EDT)
Capitalization
348.89M
PTIX
Price
$5.81
Change
-$0.33 (-5.37%)
Updated
May 22, 12:51 PM (EDT)
Capitalization
4.05M
Interact to see
Advertisement

CDTX vs PTIX

Header iconCDTX vs PTIX Comparison
Open Charts CDTX vs PTIXBanner chart's image
Cidara Therapeutics
Price$26.54
Change+$0.29 (+1.10%)
Volume$100
Capitalization348.89M
Protagenic Therapeutics
Price$5.81
Change-$0.33 (-5.37%)
Volume$760
Capitalization4.05M
CDTX vs PTIX Comparison Chart
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. PTIX commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Buy and PTIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (CDTX: $26.25 vs. PTIX: $6.14)
Brand notoriety: CDTX and PTIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 157% vs. PTIX: 49%
Market capitalization -- CDTX: $348.89M vs. PTIX: $4.05M
CDTX [@Biotechnology] is valued at $348.89M. PTIX’s [@Biotechnology] market capitalization is $4.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whilePTIX’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • PTIX’s FA Score: 1 green, 4 red.
According to our system of comparison, PTIX is a better buy in the long-term than CDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 6 TA indicator(s) are bullish while PTIX’s TA Score has 6 bullish TA indicator(s).

  • CDTX’s TA Score: 6 bullish, 4 bearish.
  • PTIX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CDTX and PTIX are a good buy in the short-term.

Price Growth

CDTX (@Biotechnology) experienced а +35.98% price change this week, while PTIX (@Biotechnology) price change was +87.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was -1.66%.

Reported Earning Dates

CDTX is expected to report earnings on May 08, 2025.

PTIX is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($349M) has a higher market cap than PTIX($4.05M). CDTX YTD gains are higher at: -2.344 vs. PTIX (-10.496). PTIX has higher annual earnings (EBITDA): -5.48M vs. CDTX (-192.6M). CDTX has more cash in the bank: 168M vs. PTIX (1.84M). PTIX has less debt than CDTX: PTIX (420K) vs CDTX (2.67M). CDTX has higher revenues than PTIX: CDTX (302K) vs PTIX (0).
CDTXPTIXCDTX / PTIX
Capitalization349M4.05M8,613%
EBITDA-192.6M-5.48M3,518%
Gain YTD-2.344-10.49622%
P/E RatioN/AN/A-
Revenue302K0-
Total Cash168M1.84M9,140%
Total Debt2.67M420K636%
FUNDAMENTALS RATINGS
CDTX vs PTIX: Fundamental Ratings
CDTX
PTIX
OUTLOOK RATING
1..100
7994
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3635
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTIX's Valuation (26) in the null industry is somewhat better than the same rating for CDTX (79) in the Biotechnology industry. This means that PTIX’s stock grew somewhat faster than CDTX’s over the last 12 months.

PTIX's Profit vs Risk Rating (100) in the null industry is in the same range as CDTX (100) in the Biotechnology industry. This means that PTIX’s stock grew similarly to CDTX’s over the last 12 months.

PTIX's SMR Rating (100) in the null industry is in the same range as CDTX (100) in the Biotechnology industry. This means that PTIX’s stock grew similarly to CDTX’s over the last 12 months.

PTIX's Price Growth Rating (35) in the null industry is in the same range as CDTX (36) in the Biotechnology industry. This means that PTIX’s stock grew similarly to CDTX’s over the last 12 months.

PTIX's P/E Growth Rating (100) in the null industry is in the same range as CDTX (100) in the Biotechnology industry. This means that PTIX’s stock grew similarly to CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXPTIX
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 22 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEQZX59.24N/A
N/A
GuideStone Funds Equity Index Investor
IVITX22.44N/A
N/A
VY® Invesco Growth and Income S2
ABRFX14.99N/A
N/A
DSS AmericaFirstMonthlyRisk-OnRisk-Off A
MPLAX14.34N/A
N/A
Praxis International Index A
RGGRX18.08N/A
N/A
Victory RS Global R6

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-2.42%
BPTSY - CDTX
92%
Closely correlated
N/A
REPL - CDTX
40%
Loosely correlated
-7.94%
IVVD - CDTX
36%
Loosely correlated
-5.52%
CPRX - CDTX
35%
Loosely correlated
-1.46%
RCKT - CDTX
34%
Loosely correlated
-3.80%
More

PTIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTIX has been loosely correlated with ARMP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PTIX jumps, then ARMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTIX
1D Price
Change %
PTIX100%
-10.76%
ARMP - PTIX
45%
Loosely correlated
-6.67%
TNGX - PTIX
30%
Poorly correlated
-8.70%
SQZB - PTIX
26%
Poorly correlated
N/A
CDTX - PTIX
25%
Poorly correlated
-2.42%
OCGN - PTIX
25%
Poorly correlated
+2.47%
More